A61K 45 - Medicinal preparations containing active ingredients not provided for in groups

Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
10/2001
10/25/2001	CA2406190A1 Screening method for compounds
10/25/2001	CA2405781A1 Secreted proteins
10/25/2001	CA2405451A1 Molecules associated with human reproduction
10/25/2001	CA2405377A1 Nutritional modules
10/25/2001	CA2405238A1 Single-dose antihistamine/decongestant formulations for treating rhinitis
10/25/2001	CA2405233A1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
10/25/2001	CA2404858A1 Treatment of neurodegenerative disease
10/25/2001	CA2404117A1 Use of ngf-antagonists for the prevention or treatment of chronic visceral pain
10/25/2001	CA2403644A1 Drug metabolizing enzymes
10/25/2001	CA2403547A1 Purified and isolated potassium-chloride cotransporter nucleic acids and polypeptides and therapeutic and screening methods using same
10/25/2001	CA2403490A1 N-substituted dithiocarbamates for the treatment of biological disorders
10/25/2001	CA2399940A1 Enhancement of antibody-mediated immune responses
10/25/2001	CA2370572A1 Kv10.1, a novel voltage-gated potassium channel from human brain
10/25/2001	CA2370487A1 Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
10/24/2001	EP1148054A1 Thyroid receptor ligands
10/24/2001	EP1147771A1 Pharmaceutical formulation containing amoxycillin and clavulanate
10/24/2001	EP1147770A1 Virginiamycin mixture
10/24/2001	EP1147413A2 Growth differentiation factor inhibitors and uses therefor
10/24/2001	EP1147223A1 Identifying, monitoring, and treating women for breast precancer or cancer
10/24/2001	EP1147193A1 Platelet-derived growth factor/vascular endothelial growth factor-like growth factor h, and uses thereof
10/24/2001	EP1147191A1 Transcriptional regulation of the human beta3-adrenergic receptor gene
10/24/2001	EP1147136A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
10/24/2001	EP1147134A1 Novel potassium channels and genes encoding these potassium channels
10/24/2001	EP1147133A2 Pth functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules
10/24/2001	EP1147094A1 Non-peptide glp-1 agonists
10/24/2001	EP1146913A2 Conjugates of colony stimulating factors for targeting and imaging infection and inflammation
10/24/2001	EP1146909A1 Method of treating cancer by restoration of pp32 function
10/24/2001	EP1146906A1 Mucosal delivery system
10/24/2001	EP1146905A1 Cox-2 inhibitors in combination with nmda-blockers for treating pain
10/24/2001	EP1146904A1 Use of hydroxyurea and a reverse transcriptase inhibitor to induce autovaccination by autologous hiv
10/24/2001	EP1146901A1 Potentiation of anti-cd38-immunotoxin cytotoxicity
10/24/2001	EP1146899A1 Methods of using a neurotrophin and its analogues for the treatment of gastrointestinal hypomotility disorders
10/24/2001	EP1146895A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
10/24/2001	EP1146894A1 Uses of thank, a tnf homologue that activates apoptosis
10/24/2001	EP1146892A2 Baff, inhibitors thereof and their use in the modulation of the b-cell response
10/24/2001	EP1146891A1 Inhibiting development of microvessels within vascular walls
10/24/2001	EP1146888A2 Specific therapeutic interventions obtained by interference with redistribution and/or targetting
10/24/2001	EP1146884A1 Novel polymer formulations containing perfluorinated compounds for the engineering of cells and tissues for transplantation that improves cell metabolism and survival, and methods for making same
10/24/2001	EP1146881A2 Preparation for the prevention and/or treatment of a tissue change of mesenchymal origin
10/24/2001	EP1146880A2 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
10/24/2001	EP1146879A1 Methods and compositions for prevention and treatment of restenosis with non-steroidal anti-inflammatory drugs
10/24/2001	EP1146878A1 Biochemical compositions used in human treatment
10/24/2001	EP1146874A1 Vitronectin receptor antagonist
10/24/2001	EP1146873A1 Anti-androgens and methods for treating disease
10/24/2001	EP1146872A1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction
10/24/2001	EP1146869A2 Inhibition of stat3 signal transduction for human cancer therapy
10/24/2001	EP1146866A1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor
10/24/2001	EP1146861A1 Hydrogel particle formulations
10/24/2001	EP1146859A1 Method of preparing particles for agglomeration
10/24/2001	EP1146851A1 Galenic formulation containing biotin
10/24/2001	EP1146845A2 Compressed lecithin preparations
10/24/2001	EP1146789A1 Treating cancers associated with overexpression of her-2/neu
10/24/2001	EP1146788A1 Amide derivatives for antiangiogenic and/or antitumorigenic use
10/24/2001	EP1146787A1 Methods for identifying, treating or monitoring asymptomatic patients for risk reduction or therapeutic treatment of breast cancer
10/24/2001	EP0840601B1 Thip for treating sleep disorders
10/24/2001	CN1319131A Method and compositions useful for modulation of angiogenesis using tyrosine kinase SRC
10/24/2001	CN1319088A Arylsulfonanilide ureas
10/24/2001	CN1319021A Chemokine receptor antagonist and ocyclosporin in combined therapy
10/24/2001	CN1319013A Pharmaceutical agents for treatment of parkinson's diseae, ADHD and microadenomas
10/24/2001	CN1319012A Method for treating diabetes employing ap2 inhibitor and combination
10/24/2001	CN1319009A Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/24/2001	CN1318372A Application of insulin sensitizing agent in treatment of nephrosis
10/24/2001	CN1073422C Use of progestin for preparing medicine for reducing endometrorrhagia
10/24/2001	CN1073421C Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta adrenergic antagonist
10/23/2001	US6307027 Bradykinin B1 receptor antibodies
10/23/2001	US6307021 Polypeptide; for use in the treatment of defects associated with amplified or decreased apoptosis
10/23/2001	US6306912 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases
10/23/2001	US6306909 Anti-epileptogenic agents
10/23/2001	US6306900 Enteric coated pharmaceutical compositions
10/23/2001	US6306898 Mixture of vitamin e and squalane for skin disorders
10/23/2001	US6306897 Calanolides for inhibiting BTK
10/23/2001	US6306891 Inhibitors of hiv integrase and inhibitors of hiv replication. these compounds are useful in the prevention or treatment of infection by hiv treatment of aids, either as compounds, pharmaceutically acceptable salts
10/23/2001	US6306876 4-[aryl(8-azabicyclo[3.2.1]octan-3-yl)]aminobenzoic acid derivatives
10/23/2001	US6306874 Enzyme inhibitors such as angiogenesis, cancer, tumor growth, atherosclerosis, age related macular degeneration, diabetic retinopathy, inflammatory diseases, and the like in mammals.
10/23/2001	US6306841 Treatment of female sexual dysfunction
10/23/2001	US6306838 Targeted vesicular constructs for cyto protection and treatment of h. pylori
10/23/2001	US6306834 Methods of treating or preventing radiation, mutagen and sunlight-induced biological damage, methods for improving wound healing and tissue repair, comprising administering the compositions of the present invention to an animal.
10/23/2001	US6306820 Combination therapy using a TNF binding protein for treating TNF-mediated diseases
10/23/2001	US6306819 Method for regulating size of vascularized normal tissue
10/23/2001	US6306612 Methods of facilitating vascular growth
10/23/2001	US6306453 Anti-stress agents for aquatic animals
10/23/2001	US6306439 Expandable pharmaceutical forms
10/23/2001	US6306403 Intracranial administration of botulinum toxin into a globus palladius or into ventrolateral thalamus, thereby reducing a dyskinesia of parkinson's disease
10/23/2001	US6306385 Method of protecting against chronic infections
10/23/2001	US6306369 Comprising bronchodilatory agent, anti-infalmmatory agent and 1,1,1,2-tetrafluoroethane propellent; for administration of medicaments by inhalation; for therapy of respiratory system disorders
10/23/2001	US6305380 Administering histamine agonist or ht3 receptor antagonist to activate natural killer cells and treat viral diseases
10/18/2001	WO2001077687A2 Prion-binding peptidic ligands and methods of using same
10/18/2001	WO2001077342A1 Multivalent antibodies and uses therefor
10/18/2001	WO2001077339A1 Human pyruvate dehydrogenese phosphatase
10/18/2001	WO2001077338A2 Human protein kinases and protein kinase-like enzymes
10/18/2001	WO2001077335A2 Listeria monocytogenes genome, polypeptides and uses
10/18/2001	WO2001077327A1 THE HIGH BONE MASS GENE OF 11q13.3
10/18/2001	WO2001077297A1 Specific inhibitors of ribosome recycling factor (rrf)
10/18/2001	WO2001077174A2 Human transporters and ion channels
10/18/2001	WO2001077170A2 Multiprotein-complexes comprising a nmda receptor and uses thereof
10/18/2001	WO2001077169A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
10/18/2001	WO2001077150A2 Serine-threonine kinase
10/18/2001	WO2001077149A2 Regulation of human cyslt2-like gpcr protein
10/18/2001	WO2001077147A2 New bromodomain protein
10/18/2001	WO2001077114A1 Inhibitors of prenyl-protein transferase

1 ... 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 ... 1151